Evaluation of Pericardial Effusions in Alopecia Patients on Low-Dose Oral Minoxidil Therapy
- Samson Clinical
- Dec 10, 2024
- 1 min read
Updated: Feb 26
Colin M. Kincaid MDa, Ajay N. Sharma MD MBAa, Brynn Sargent MDa, Irmina Gradus-Pizlo MDb, Elizabeth H. Dinee - Journal of the American Academy of Dermatology (jaad).
September 2024 | Volume 23 | Issue 9 | 725 | Copyright © September 2024
Low-dose oral minoxidil (LDOM) is being increasingly prescribed off-label as an adjunct treatment for alopecia. Historically, minoxidil has primarily been used as a treatment for severe, refractory hypertension due to its potent vasodilating properties.
In this study, an association between LDOM therapy and pericardial effusions was evaluated by using ultrasound to compare the frequency of pericardial effusions in alopecia patients on LDOM therapy compared to those not on LDOM.